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Two disorders, periventricular nodular heterotopia (PVNH) and a group of skeletal dysplasias belonging to the
oto-palato-digital (OPD) spectrum, are caused by FLNA mutations. They are considered mutually exclusive because
of the different presumed effects of the respective FLNA gene mutations, leading to loss of function (PVNH) and
gain of function (OPD), respectively. We describe here the first patient manifesting PVNH in combination with
frontometaphyseal dysplasia, a skeletal dysplasia of the OPD-spectrum. A novel de novo mutation, 7315CrA in
exon 45 of the FLNA gene, was identified. It leads to two aberrant transcripts, one full-length transcript with the
point mutation causing a substitution of a highly conserved leucine residue (L2439M) and a second shortened
transcript lacking 21 bp due to the creation of an ectopic splice donor site in exon 45. We propose that the dual
phenotype is caused by two functionally different, aberrant filamin A proteins and therefore represents an exceptional
model case of allelic gain-of-function and loss-of-function phenotypes due to a single mutational event.
Filamin A is a ubiquitous actin-binding protein involved
in cytoskeletal organization. It has three major functional
domains: N-terminal actin–binding domain, rod domain
consisting of 24 immunoglobulinlike repeat units inter-
rupted by two flexible hinge structures, and a C-terminal
dimerization site (fig. 1) (Stossel et al. 2001; van der Flier
and Sonnenberg 2001). Mutations in FLNA, the human
filamin A gene, were first detected in periventricular nodu-
lar heterotopia (PVNH [MIM 300049]), an X-linked neu-
ronal migration disorder that affects predominantly fe-
males and leads to early prenatal lethality in males (Fox
et al. 1998). The majority of FLNA mutations associated
with PVNH are truncating mutations, indicating that loss
of filamin A function causes PVNH (Fox et al. 1998;
Sheen et al. 2001; Moro et al. 2002; Human Gene Mu-
tation Database). More recently, it was demonstrated that
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mutations in FLNA are also associated with a group of
X-linked skeletal dysplasias subsumed as oto-palato-dig-
ital (OPD) syndrome spectrum disorders comprising
OPD1 (MIM 311300), OPD2 (MIM 304120), Melnick-
Needles syndrome (MNS [MIM 309350]), and fronto-
metaphyseal dysplasia (FMD [MIM 305620]) (Robertson
et al. 2003). In contrast to PVNH, all FLNA mutations
detected in OPD-spectrum disorders are missense muta-
tions or small deletions/insertions conserving the reading
frame and apparently clustering in certain domains of the
gene. It was proposed that OPD-spectrum disorders result
from gain of function or altered binding affinity of filamin
A for unidentified protein partners (Robertson et al.
2003). This concept renders these phenotypes almost in-
compatible in the same individual. Exceptions to that rule,
as described in this report, should therefore be of partic-
ular interest and provide further insights into FLNA mu-
tational effects.
The proposita is the second daughter of healthy, un-
related parents with an unremarkable family history.
Skeletal abnormalities became evident during childhood:
delayed closure of the anterior fontanel, craniofacial
anomalies, and marked genua valga necessitating re-
peated surgical corrections. Motor development and
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Figure 1 Diagram showing the structure of the filamin A homo-
dimer, functional domains (left), and localization of the previously
described and the novel mutations (right). Adapted from Stossel et al.
(2001).
mental development were normal. Body height devel-
oped in the range of the 3rd–10th percentiles. Cranial
magnetic resonance imaging (MRI) performed at age 5
years incidentally showed bilateral PVNHs (fig. 2a). The
patient never had seizures. When examined first in our
department at age 8 years, the girl presented with typical
clinical features of FMD (fig. 2b–2d). Radiological
anomalies confirmed the diagnosis of FMD (fig. 2e–2h).
The patient’s mother had a normal clinical phenotype
and cranial MRI.
The patient’s karyotype was normal. The whole cod-
ing region of FLNA was analyzed by bidirectional direct
sequencing by use of an ABI 3730 automated sequencer
(Applied Biosystems). Primer sequences and PCR condi-
tions are available on request. We identified a heterozy-
gous mutation, 7315CrA, in exon 45, predicting a sub-
stitution of leucine by methionine (L2439M). The muta-
tion was not present in either of the parents (fig. 3a).
We confirmed paternity by testing the segregation of
16 microsatellite markers from different chromosomes
(PowerPlex 16 [Promega]). PCR with allele-specific for-
ward primers for a polymorphism in intron 45 (IVS45-
64TrC [dbSNP accession number rs2070819]), for
which the index patient was heterozygous, and an op-
posite primer designed to include the site of the mutation
in exon 45 disclosed that the mutation had emerged on
the paternally inherited X-chromosome (details available
on request). The mutation 7315CrA was not found in
192 control chromosomes.
We excluded larger genomic deletions of the second
FLNA allele with Southern blot analysis, using PCR-
derived genomic probes from the FLNA gene, as well
as metaphase FISH with the cosmid probe Scos10 con-
taining the entire FLNA gene (Patrosso et al. 1994) (de-
tails available on request). Both gave normal results. In
addition, FLNA sequence analysis showed heterozygos-
ity in the patient for known polymorphisms in the in-
trons 5, 33, 43, and 45 and exon 36, thereby excluding
deletions of the respective regions.
FLNA expression was studied on total RNA ex-
tracted from blood cells and skin fibroblasts. A 409-
bp cDNA fragment containing the entire exon 45 and
parts of the flanking exons was amplified by RT-PCR
(details available on request). Besides confirmation of
the expression of the mutant 7315CrA, the cDNA se-
quence indicated the presence of a second aberrant
transcript lacking 21 nucleotides (fig. 3b). An-
alysis of sequence motifs revealed that the mutation
7315CrA creates an ectopic-splice donor site in exon
45. The consensus sequence for a 5′ splice donor is
A58G78g100t100a/g96a71g84t47, in which exon nucleotides
are shown in uppercase and intron nucleotides in low-
ercase letters, and the numbers indicate the percentage
occurrence of the different nucleotides (Ketterling et al.
1999). The CrA exchange corresponds to position 3
of the newly created splicing signal AGgtatgg that
matches the consensus sequence almost perfectly. The
splice-prediction program Splice-View, which uses the
weight matrix in accordance with the method of Shapiro
and Senapathy (1987), predicts the ectopic-donor splice
site with a high probability (.87). This is only slightly
less than the score of .95 calculated for the authentic 5′
splice site of exon 45. Premature 5′ splicing of exon 45
predicts an in-frame deletion of seven amino acid resi-
dues in the filamin A protein (del L2439-G2445). For
confirmation, RT-PCR products derived from fibroblasts
were cloned in Escherichia coli by use of the TOPO TA
Cloning kit (Invitrogen) and One Shot (Invitrogen) (fig.
3c–3e). In 25 successfully transfected clones, the wild-
type allele and the shortened transcript (FLNAD7) were
both found nine times, and the transcript with the point
mutation (FLNAL2439M) was found seven times. In ad-
dition, presence of the shortened transcript in lympho-
cytes and fibroblasts was demonstrated by agarose gel
electrophoresis (fig. 3f).
Since the androgen receptor gene polymorphism usu-
ally used for studying the X-inactivation pattern (Allen
et al. 1992) was uninformative, we tested differential
methylation of the FMR1 locus with a technique similar
to one described elsewhere (Carrel and Willard 1996), as
well as expression of coding SNPs within FLNA (dbSNP
accession number rs2070825) and TIMP1 (dbSNP ac-
cession number rs4898) by RT-PCR. Consistently, in
blood cells almost equal inactivation of both alleles was
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Figure 2 a, Cranial MRI of the patient at age 5 years, showing typical PVNHs (arrows). b–d, Clinical photographs of the patient at age
7 years: massively prominent supraorbital ridges; large-appearing eyes with hypertelorism; receding, pointed chin; slender, deformed thorax;
genua valga et recurvata; and extension deficit in the elbows. e–h, Radiological findings of the patient at age 7 years. e, Skull radiograph showing
increased density of the skull, with deficient pneumatization of mastoid and sinuses and a widely open anterior fontanel. f, Radiograph of the
pelvis and hips, showing coxa valga et antetorta, with widened femoral necks. Radiographs of the right distal forearm and hand (g) and of the
knees and lower legs (h), showing metaphyseal widening of long bones, short terminal phalanges, genua valga, and slight bending of tibiae and
fibulae.
found; in fibroblasts, a distribution of roughly 70:30 in
favor of the paternally inherited X-chromosome carrying
the mutation was found (data not shown). This is in
accordance with the RT-PCR results demonstrated in
figure 3b.
Clinical and molecular findings in this unique patient
demonstrate, for the first time (to our knowledge), an
overlap of PVNH and OPD-spectrum disorders, and it
is tempting to assume that the combination of both phe-
notypes is caused by the presence of two different ab-
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Figure 3 a, Sequence traces from genomic DNA of the patient
and her clinically normal parents, showing the heterozygous CrA
exchange position, 7315, in the patient and absence of the mutation
in both parents. b–e, Demonstration of the expression of two different
aberrant FLNA transcripts in fibroblasts. b, Electropherogram derived
from sequencing of the RT-PCR products from fibroblast mRNA,
showing the presence of a shortened alternative transcript lacking 21
bases from exon 45. The normal sequence of the exons 45 and 46 are
indicated above in black and blue, respectively. The position of the
point mutation 7315CrA is depicted in red and marked by red arrows.
Note that the T peak at position of the mutation is higher than the
C representing the wild-type allele. Predominance of the mutant allele
reflects the X-inactvation pattern. c–e, Sequences from different clones
of the RT-PCR product cloned in E. coli. All three transcripts predicted
from the sequencing results in panel b could be detected: 21-bp deletion
(c), wild-type allele (d), and point mutation (e). f, Electrophoresis of
a 409-bp RT-PCR fragment on a 2.5% agarose gel, showing presence
of a shortened fragment in the patient’s lymphocytes (lym) and fibro-
blasts (fib) but not in a normal male control (con). Ø p no template
control.
errant transcripts. In the shortened protein (FLNAD7), a
central strand in the b-sheet complex of the immuno-
globulinlike rod domain unit 23 is deleted (fig. 4a), pre-
dicting a significant disruption of its conserved structure.
Moreover, owing to sterical interrelationship, the dele-
tion might also influence structure or stability of the
following hinge region or repeat 24, which is essential
for dimerization (Stossel et al. 2001; van der Flier and
Sonnenberg 2001). These considerations justify the as-
sumption that the mutant FLNAD7 causes loss of func-
tion, which is the presumed mechanism for PVNH. Mu-
tations, published elsewhere, in PVNH leading to loss
of the most-carboxyterminal portion of the filamin A
protein (Sheen et al. 2001; Moro et al. 2002) indicate that
integrity of the C-terminal repeats is essential for filamin
A function in neuronal migration. In contrast, the amino
acid exchange in the full-length mutant (mutant
FLNAL2439M) is not predicted to have significant impact
on the filamin A repeat structure, but it leads to substi-
tution of a highly conserved amino acid (fig. 5). In a
structural model, the amino acid residue 2439 is imbed-
ded in a large nonpolar surface area, representing a pos-
sible candidate for protein-protein interactions (fig. 4b).
Moreover, since methionine residues are known to play
important roles in recognition and binding of nonpolar
surfaces in protein-protein interactions (Gellman 1991),
it might be speculated that the mutant FLNAL2439M has
the potential to alter binding of unidentified protein part-
ners, in accordance with the proposed effects of muta-
tions in the filamin A rod domain associated with OPD-
spectrum disorders (Robertson et al. 2003). Functional
experiments, which were out of the scope of the present
study, are still needed to clarify the pathogenic mecha-
nisms of mutations associated with OPD-spectrum
disorders.
The findings that the mutation described here is not
localized in the proximity of the clusters reported else-
where (fig. 1) and that there is no skewing of X-inac-
tivation against the mutant allele might raise concerns
against its pathogenic significance with respect to FMD.
The current knowledge on molecular mechanisms in
FMD, however, is based on only three patients with mu-
tations in different repeats (10 and 14) of the filamin A
rod domain and on two females with documented skew-
ing of X-inactivation (Robertson et al. 2003). On the
other hand, the published data shows that negative se-
lection against cells in which the mutant is active is not
absolute in female carriers for OPD-spectrum disorders
(Robertson et al. 2003) and that a less-skewed X-inac-
tivation pattern may be related to clinical affection status
(Robertson et al. 2001). In a further patient with FMD
who also lacks significant skewing of X-inactivation, we
recently identified a novel de novo missense mutation in
repeat 15 (unpublished data). In conclusion, there is ob-
viously no single mutation hotspot in FMD that would
bring the findings presented here in substantial conflict
with current pathogenic concepts.
Even if there is convincing evidence that the two
aberrant transcripts have divergent functional conse-
quences, it deserves further consideration how their co-
expression in those cells, in which the mutant X-chro-
mosome is active, can lead to the manifestation of both
phenotypes. It is obvious that different tissues have very
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Figure 4 Three-dimensional models of the filamin A rod domain repeat unit 23, generated on the basis of the homologous structures of
the 4th (Fucini et al. 1997) and 5th (McCoy et al. 1999) module of the F-Actin Cross-Linking Gelation Factor (Abp-120) by use of Swiss-
Model (Guex and Peitsch 1997; Protein Data Bank). a, Ribbon model of a repeat unit showing, in cyan, the regular position of the strand
deleted in the shortened protein. Amino- and carboxyterminal ends of the repeat are marked by N- and -C, respectively. b, Model showing the
respective position of the leucine residue corresponding to position 2439 depicted in cyan. It resides in a hydrophobic surface cluster. Nonpolar
residues are shown in red.
Figure 5 Alignment of the beginning of filamin A repeat 23 and filamin A homologues from various species, as well as the human
paralogues filamin B and C (GenBank), showing conservation of the leucine residue at position 2439 (white frames on black background). The
conserved amino acids are shown with black background and similar amino acids with a gray background. Numbers above indicate amino
acid position in the filamin A protein (GenBank accession number NP_001447).
different sensitivity to specific filamin A mutants: the
virtual lack of extracerebral manifestations in patients
with PVNH in the presence of a random X inactivation
in blood cells (Fox et al. 1998) clearly indicates that a
simple loss of function of filamin A does not result in a
selective disadvantage or phenotypic consequences in
other tissues. In contrast, skeletal tissue is particularly
sensitive to a special kind of functionally abnormal fi-
lamin A, whereas the same mutant functions normally
in neuronal migration, as evidenced by the absence of
cerebral features compatible with a neuronal migration
defect even in male patients with OPD-spectrum disor-
ders (Verloes et al. 2000; Robertson et al. 2003). Ac-
cordingly, we postulate that in the state of coexpression
of the two mutants in skeletal tissue, the functionally
defective filamin A mutant (presumably FLNAD7) is phe-
notypically silent, whereas the presence of a protein with
abnormal (potentially increased) function (presumably
FLNAL2439M) gives rise to the features of FMD. On the
other hand, if it is true that filamin A mutants responsible
for the manifestations of FMD have the potential to
function normally in terms of neuronal migration,
shouldn’t the mutant FLNAL2439M be able to compensate
for the coexpressed functionally defective mutant in neu-
rons and thereby rescue the neuronal phenotype? The
clue may be that the initiation of neuronal migration is
a process highly sensitive to filamin A dosage or its dy-
namic recruitment. It has been shown that a rise in in-
tracellular filamin A availability following the decrease
in activity of the filamin A-interacting protein FILIP is
the critical physiological impulse for neurons to leave
the ventricular zone (Nagano et al. 2002). Cells consti-
tutionally producing a significant proportion of non-
functional filamin A may not be able to cope with these
dynamic requirements.
The present observation highlights the importance of
determining the effect of point mutations on mRNA ex-
pression. Splicing can be affected by different mechanisms
even if mutations are not located within the authentic
splice-recognition sites (Cartegni et al. 2002). The pres-
736 Am. J. Hum. Genet. 74:731–737, 2004
ence of multiple aberrant transcripts due to mutations
affecting 5′ splicing is not rare (Roca et al. 2003). How-
ever, the production of two aberrant transcripts, presum-
ably leading to loss and gain of function due to a single
mutational event, renders this mutation an exceptional
model for mechanisms that can underlie the overlap of
otherwise mutually exclusive allelic phenotypes.
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